Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?

AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer on key metrics. https://www.nasdaq.com/articles/pfizer-or-astrazeneca-which-stock-offers-better-long-term-potential